CKD Bio Corp. (063160.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩12,100 (-1.63%) as of
Key statistics
- Market cap
- 66.38B
- Dividend yield
- 0.00%
- 52-week range
- 11,770.00 – 24,900.00
- Beta
- 0.59
- Revenue (TTM)
- 159.93B
- Profit margin
- -14.46%
- Volume
- 5.05k
About CKD Bio Corp.
CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
- Employees
- 519
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.